Intrafollicular location of marginal zone/CD1dhi B cells is associated with autoimmune pathology in a mouse model of lupus

Laboratory Investigation

Volumn 88, Issue 9, 2008, Pages 1008-1020

  Duan, Biyan ^a,d   Niu, Haitao ^a   Xu, Zhiwei ^a   Sharpe, Arlene H ^b   Croker, Byron P ^a,c   Sobel, Eric S ^a   Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; B cells; Macrophages; Marginal zone; Systemic lupus erythematosus

Indexed keywords

CD1D ANTIGEN; CXCL13 CHEMOKINE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGENS, CD1; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL;

EID: 50249092708     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2008.62     Document Type: Article

References (55)

1. Kraal G, Mebius R. New insights into the cell biology of the marginal zone of the spleen. Int Rev Cytol 2006;250:175-215.
2. Martin F, Oliver AM, Kearney JF. Marginal zone and B1B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001;14:617-629.
3. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004;172:803-811.
4. Oliver AM, Martin F, Kearney JF. IgM(high)CD21(high) lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999;162:7198-7207.
5. Ansel KM, Ngo VN, Hyman PL, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000;406:309-314.
6. Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002;297:409-412.
7. Cinamon G, Matloubian M, Lesneski MJ, et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol 2004;5:713-720.
8. Vora KA, Nichols E, Porter G, et al. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement. J Leukoc Biol 2005;78:471-480.
9. Karlsson MCI, Guinamard R, Bolland S, et al. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 2003;198:333-340.
10. Nolte MA, Arens R, Kraus M, et al. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol 2004;172:3620-3627.
11. Lopes-Carvalho T, Kearney JF. Development and selection of marginal zone B cells. Immunol Rev 2004;197:192-205.
12. H genes and are ligand selected. J Immunol 2000;165:6156-6169.
13. Dunn-Walters DK, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 1995;182:559-566.
14. Wither JE, Roy V, Brennan LA. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F-1 mice. Clin Immunol 2000;94:51-63.
15. Grimaldi CM, Michael DJ, Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001;167:1886-1890.
16. Li YJ, Li H, Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Exp 2002;195:181-188.
17. Wither JE, Loh C, Lajoie G, et al. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J Immunol 2005;175:4309-4319.
18. Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999;190:1697-1710.
19. Duan B, Croker BP, Morel L. Lupus resistance is associated with marginal zone abnormalities in an NZM murine model. Lab Invest 2007;87:14-28.
20. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells. J Exp Med 2000;191:883-889.
21. Liu Y, Li L, Kumar KR, et al. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J Immunol 2007;179:1340-1352.
22. Li Y, Li H, Ni D, et al. Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J Exp Med 2002;196:1543-1552.
23. Morel L, Croker BP, Blenman KR, et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci USA 2000;97:6670-6675.
24. Oliver AM, Martin F, Gartland GL, et al. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997;27:2366-2374.
25. Freeman GJ, Borriello F, Hodes RJ, et al. Uncovering of functional alternative Ctla-4 counter-receptor in B7-deficient mice. Science 1993;262:907-909.
26. Sobel ES, Mohan C, Morel L, et al. Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells. J Immunol 1999;162:2415-2421.
27. Xu Z, Duan B, Croker BP, et al. STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus. Clin Immunol 2006;120:189-198.
28. Erickson LD, Lin LL, Duan B, et al. A genetic lesion that arrests plasma cell homing to the bone marrow. Proc Natl Acad Sci USA 2003;100:12905-12910.
29. Makowska A, Faizunnessa NN, Anderson P, et al. CD1high B cells: a population of mixed origin. Eur J Immunol 1999;29:3285-3294.
30. Rolf J, Motta V, Duarte N, et al. The enlarged population of marginal zone/CD1dhigh B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J Immunol 2005;174:4821-4827.
31. Mohan C, Yu Y, Morel L, et al. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol 1999;162:6492-6502.
32. Gunn KE, Brewer JW. Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity. J Immunol 2006;177:3791-3798.
33. Ng LG, Sutherland AP, Newton R, et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 2004;173:807-817.
34. Smith SH, Cancro MP. Cutting Edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J Immunol 2003;170:5820-5823.
35. Lesley R, Xu Y, Kalled SL, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004;20:441-453.
36. Srivastava B, Lindsley RC, Nikbakht N, et al. Models for peripheral B cell development and homeostasis. Semin Immunol 2005;17:175-182.
37. Cinamon G, Zachariah MA, Lam OM, et al. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 2008;9:54-62.
38. Mandik-Nayak L, Racz J, Sleckman BP, et al. Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help. J Exp Med 2006;203:1985-1998.
39. Chen X, Martin F, Forbush KA, et al. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 1997;9:27-41.
40. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005;23:127-159.
41. Lo CG, Lu TT, Cyster JG. Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med 2003;197:353-361.
42. Dang LH, Rock KL. Stimulation of B lymphocytes through surface Ig receptors induces LFA-1 and ICAM-1-dependent adhesion. J Immunol 1991;146:3273-3279.
43. Debnath I, Roundy KM, Weis JJ, et al. Defining in vivo transcription factor complexes of the murine CD21 and CD23 genes. J Immunol 2007;178:7139-7150.
44. Mohan C, Morel L, Yang P, et al. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol 1997;159:454-465.
45. Wu T, Qin X, Kurepa Z, et al. Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest 2007;117:2186-2196.
46. Liang B, Kashgarian MJ, Sharpe AH, et al. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J Immunol 2000;165:3436-3443.
47. Collins AV, Brodie DW, Gilbert RJC, et al. The interaction properties of costimulatory molecules revisited. Immunity 2002;17:201-210.
48. Jansson A, Barnes E, Klenerman P, et al. A theoretical framework for quantitative analysis of the molecular basis of costimulation. J Immunol 2005;175:1575-1585.
49. Pentcheva-Hoang T, Egen JG, Wojnoonski K, et al. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004;21:401-413.
50. Zheng Y, Manzotti CN, Liu M, et al. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol 2004;172:2778-2784.
51. Butte MJ, Keir ME, Phamduy TB, et al. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007;27:111-122.
52. Roy V, Bonventi G, Cai Y, et al. Immune mechanisms leading to abnormal B cell selection and activation in New Zealand Black mice. Eur J Immunol 2007;37:2645-2656.
53. Suvas S, Singh V, Sahdev S, et al. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J Biol Chem 2002;277:7766-7775.
54. Podojil JR, Kin NW, Sanders VM. CD86 and β2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 30-IgH enhancer in B cells. J Biol Chem 2004;279:23394-23404.
55. Kin NW, Sanders VM. CD86 stimulation on a B cell activates the phosphatidylinositol 3-kinase/Akt and phospholipase Cγ2/protein kinase Cαβ signaling pathways. J Immunol 2006;176:6727-6735.